[1] Silva NA, Sousa N, Reis RL and Salgado AJ. From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol 2014; 114: 25-57.
[2] Young M, McKay C, Williams S, Rouse P and Bilzon JLJ. Time-related changes in quality of life in persons with lower limb amputation or spinal cord injury: protocol for a systematic review. Syst Rev 2019; 8: 191.
[3] Zhang D, Ma G, Hou M, Zhang T, Chen L and Zhao C. The Neuroprotective Effect of Puerarin in Acute Spinal Cord Injury Rats. Cell Physiol Biochem 2016; 39: 1152-1164.
[4] He J, Zhao J, Peng X, Shi X, Zong S and Zeng G. Molecular Mechanism of MiR-136-5p Targeting NF-kappaB/A20 in the IL-17-Mediated Inflammatory Response after Spinal Cord Injury. Cell Physiol Biochem 2017; 44: 1224-1241.
[5] Chio JCT, Wang J, Badner A, Hong J, Surendran V and Fehlings MG. The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit. J Neuroinflammation 2019; 16: 141.
[6] Kigerl KA, McGaughy VM and Popovich PG. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006; 494: 578-594.
[7] Vangansewinkel T, Geurts N, Quanten K, Nelissen S, Lemmens S, Geboes L, Dooley D, Vidal PM, Pejler G and Hendrix S. Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. Faseb j 2016; 30: 2040-2057.
[8] Wang L, Yu WB, Tao LY and Xu Q. Myeloid-derived suppressor cells mediate immune suppression in spinal cord injury. J Neuroimmunol 2016; 290: 96-102.
[9] Yaguchi M, Tabuse M, Ohta S, Ohkusu-Tsukada K, Takeuchi T, Yamane J, Katoh H, Nakamura M, Matsuzaki Y, Yamada M, Itoh T, Nomura T, Toyama Y, Okano H and Toda M. Transplantation of dendritic cells promotes functional recovery from spinal cord injury in common marmoset. Neurosci Res 2009; 65: 384-392.
[10] Gadani SP and Smirnov I. Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury. 2017; 214: 285-296.
[11] Sun G and Yang S. gammadelta T cells provide the early source of IFN-gamma to aggravate lesions in spinal cord injury. 2018; 215: 521-535.
[12] Park J, Lim E, Back S, Na H, Park Y and Sun K. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res A 2010; 93: 1091-1099.
[13] Chen Z, Park J, Butler B, Acosta G, Vega-Alvarez S, Zheng L, Tang J, McCain R, Zhang W, Ouyang Z, Cao P and Shi R. Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury. J Neurochem 2016; 138: 328-338.
[14] Kim DK, Kweon KJ, Kim P, Kim HJ, Kim SS, Sohn NW, Maeng S and Shin JW. Ginsenoside Rg3 Improves Recovery from Spinal Cord Injury in Rats via Suppression of Neuronal Apoptosis, Pro-Inflammatory Mediators, and Microglial Activation. Molecules 2017; 22:
[15] David S and Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011; 12: 388-399.
[16] Martinez FO and Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6: 13.
[17] Mantovani A, Biswas SK, Galdiero MR, Sica A and Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-185.
[18] Frontera JE and Mollett P. Aging with Spinal Cord Injury: An Update. Phys Med Rehabil Clin N Am 2017; 28: 821-828.
[19] Talbott JF, Huie JR, Ferguson AR, Bresnahan JC, Beattie MS and Dhall SS. MR Imaging for Assessing Injury Severity and Prognosis in Acute Traumatic Spinal Cord Injury. Radiol Clin North Am 2019; 57: 319-339.
[20] Basso DM, Beattie MS and Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
[21] Ahuja CS, Schroeder GD, Vaccaro AR and Fehlings MG. Spinal Cord Injury-What Are the Controversies? J Orthop Trauma 2017; 31 Suppl 4: S7-s13.
[22] Skeers P, Battistuzzo CR, Clark JM, Bernard S, Freeman BJC and Batchelor PE. Acute Thoracolumbar Spinal Cord Injury: Relationship of Cord Compression to Neurological Outcome. J Bone Joint Surg Am 2018; 100: 305-315.
[23] David S, Lopez-Vales R and Wee Yong V. Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handb Clin Neurol 2012; 109: 485-502.
[24] Park J, Zheng L, Acosta G, Vega-Alvarez S, Chen Z, Muratori B, Cao P and Shi R. Acrolein contributes to TRPA1 up-regulation in peripheral and central sensory hypersensitivity following spinal cord injury. J Neurochem 2015; 135: 987-997.
[25] Due MR, Park J, Zheng L, Walls M, Allette YM, White FA and Shi R. Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat. J Neurochem 2014; 128: 776-786.
[26] He FY, Feng WZ, Zhong J, Xu W, Shao HY and Zhang YR. Effects of propofol and dexmedetomidine anesthesia on Th1/Th2 of rat spinal cord injury. Eur Rev Med Pharmacol Sci 2017; 21: 1355-1361.
[27] Lima R, Monteiro S, Lopes JP, Barradas P, Vasconcelos NL, Gomes ED, Assuncao-Silva RC, Teixeira FG, Morais M, Sousa N, Salgado AJ and Silva NA. Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection. Pharmaceuticals (Basel) 2017; 10:
[28] Kiguchi N, Kobayashi D, Saika F, Matsuzaki S and Kishioka S. Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury. J Neuroinflammation 2018; 15: 96.
[29] Zhang Y, Liu Z, Zhang W, Wu Q, Zhang Y, Liu Y, Guan Y and Chen X. Melatonin improves functional recovery in female rats after acute spinal cord injury by modulating polarization of spinal microglial/macrophages. J Neurosci Res 2019; 97: 733-743.
[30] Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ and Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
[31] Thompson CD, Zurko JC, Hanna BF, Hellenbrand DJ and Hanna A. The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma 2013; 30: 1311-1324.
[32] Zhou Z, Peng X, Insolera R, Fink DJ and Mata M. Interleukin-10 provides direct trophic support to neurons. J Neurochem 2009; 110: 1617-1627.
[33] Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S and Cathcart MK. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med 2013; 54: 1-16.
[34] Garcia E, Aguilar-Cevallos J, Silva-Garcia R and Ibarra A. Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury. Mediators Inflamm 2016; 2016: 9476020.
[35] Margul DJ, Park J, Boehler RM, Smith DR, Johnson MA, McCreedy DA, He T, Ataliwala A, Kukushliev TV, Liang J, Sohrabi A, Goodman AG, Walthers CM, Shea LD and Seidlits SK. Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel bridges. Bioeng Transl Med 2016; 1: 136-148.
[36] Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM and Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 2013; 16: 1211-1218.
[37] Miron VE and Franklin RJ. Macrophages and CNS remyelination. J Neurochem 2014; 130: 165-171.
[38] Gensel JC and Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res 2015; 1619: 1-11.